New free trade agreement sparks fight over drug pricing

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional


A push by the drug industry to raise the price of new drugs for hypertension looks set to become the battleground for the first major fight over the free trade agreement between Australia and the United States (BMJ 2004;329: 420).

The controversial agreement, which came into force on 1 January, urges recognition of innovation and gives US drug companies new mechanisms to review the Australian government's internationally recognised system of pricing drugs on the basis of evidence of their effectiveness.
Original languageEnglish
Pages (from-to)213-213
Number of pages1
JournalBMJ (Clinical research ed.)
Issue number7485
Publication statusPublished - 29 Jan 2005


Dive into the research topics of 'New free trade agreement sparks fight over drug pricing'. Together they form a unique fingerprint.

Cite this